Biomarkers in CMT2A patients


A new research project is underway, supported by our association and carried out by the team of Professor Stefania Corti of the Dino Ferrari Centre/University of Milan (Doctors Rizzo, Abati and Anastasia).

The project aims to detect in the blood of patients with CMT2A (or other pathologies due to mutation of Mitophusin 2) the presence of possible biomarkers of disease that may be useful to diagnose and/or control the development of pathology.

Biomarkers are substances in the blood of patients working as signals of the disease’s presence. They are very important for diagnosis and also to control the pathology’s development. They have not yet been investigated for CMT2A, and this is the first study doing so.

If you want more information about the research project click below 👇

Leave a Reply

Your email address will not be published. Required fields are marked *

Join our mailing list. Always stay up to date.